Video Experimental Relacionado
Updated: Aug 11, 2026
12:19
Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Estimulación de la actividad transcripcional E2F1/DP1 por la oncoproteína MDM2
K Martin1, D Trouche, C Hagemeier
1Wellcome/CRC Institute, Cambridge, UK.
Nature
|June 22, 1995
Resumen
El oncogén MDM2 promueve el cáncer al inhibir el supresor de tumores p53. Este estudio revela que MDM2 también estimula E2F1/DP1, mejorando la proliferación celular en los tumores.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Oncología Oncología.
- El Reglamento del Ciclo Celular.
Sus antecedentes:
- La amplificación de MDM2 es común en varios tumores.
- El papel oncogénico de MDM2 está relacionado con la supresión de p53.
- E2F1 y DP1 son factores de transcripción clave para la progresión de la fase S.
Objetivo del estudio:
- Investigar la interacción entre MDM2 y E2F1/DP1.1.
- Para determinar el efecto de MDM2 en la actividad de E2F1/DP1.
Principales métodos:
- Pruebas bioquímicas para estudiar las interacciones proteína-proteína.
- Análisis funcionales para evaluar la actividad transcripcional.
Principales resultados:
- MDM2 se pone en contacto directamente con el dominio de activación E2F1.
- La unión de MDM2 a E2F1/DP1 mejora su actividad transcripcional.
- Esta estimulación contrasta con el efecto represivo de MDM2 en p53.
Conclusiones:
- MDM2 promueve el crecimiento tumoral inhibiendo p53 y estimulando E2F1/DP1.
- MDM2 aumenta activamente la proliferación celular a través de la modulación del factor de transcripción.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...